Profound Medical Corp. Files 6-K, Reports Press Release
Ticker: PROF · Form: 6-K · Filed: Mar 7, 2024 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 6-K |
| Filed Date | Mar 7, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release, sec-report
TL;DR
Profound Medical Corp. filed a 6-K on March 7, 2024, with an attached press release.
AI Summary
Profound Medical Corp. filed a Form 6-K on March 7, 2024, to report a press release dated the same day. The company is incorporated in Ontario and its principal executive office is located in Mississauga. This filing indicates they will file annual reports under Form 40-F.
Why It Matters
This filing signals that Profound Medical Corp. is providing updated information to the SEC, likely related to recent business developments or announcements.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves to attach a press release, indicating no immediate material financial changes or significant events are being disclosed within the filing itself.
Key Players & Entities
- Profound Medical Corp. (company) — Registrant
- March 7, 2024 (date) — Filing and Press Release Date
- Mississauga, Ontario (location) — Principal Executive Office
- Form 40-F (document) — Annual Report Filing Type
- Exhibit 99.1 (document) — Attached Press Release
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K filing is to report a press release dated March 7, 2024, as an exhibit.
What is the company's name and location?
The company's name is Profound Medical Corp., and its principal executive office is located at 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5.
What type of annual report does Profound Medical Corp. file?
Profound Medical Corp. files its annual reports under cover of Form 40-F.
What is the filing date of this report?
This Form 6-K was filed on March 7, 2024.
What exhibit is attached to this filing?
Exhibit 99.1, a press release dated March 7, 2024, is attached to this filing.
Filing Stats: 165 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2024-03-07 16:10:05
Filing Documents
- f6k_030724.htm (6-K) — 4KB
- exh_991.htm (EX-99.1) — 158KB
- 0001171843-24-001229.txt ( ) — 164KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PROFOUND MEDICAL CORP. (Registrant) Date: March 7, 2024 /s/ Rashed Dewan Rashed Dewan Chief Financial Officer